Thursday, August 9, 2018

Oncogene - Table of Contents alert Volume 37 Issue 32

If you are unable to see the message below, click here to view.


Volume 37, Issue 32

In this issue
Review Article
Also new

Review Article

Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics

Ellen Puré & Rachel Blomberg

Oncogene 2018 37 :4343 - 4357; May 03, 2018; 10.1038/s41388-018-0275-3

Abstract | Full Text


DNA methyltransferase 3A isoform b contributes to repressing E-cadherin through cooperation of DNA methylation and H3K27/H3K9 methylation in EMT-related metastasis of gastric cancer

He Cui, Ying Hu, Didi Guo, Aifeng Zhang, Yuejun Gu et al.

Oncogene 2018 37 :4358 - 4371; May 02, 2018; 10.1038/s41388-018-0285-1

Abstract | Full Text

A novel three-dimensional high-throughput screening approach identifies inducers of a mutant KRAS selective lethal phenotype

Smitha Kota, Shurong Hou, William Guerrant, Franck Madoux, Scott Troutman et al.

Oncogene 2018 37 :4372 - 4384; May 10, 2018; 10.1038/s41388-018-0257-5

Abstract | Full Text

Antagonizing CD105 enhances radiation sensitivity in prostate cancer

Anisha Madhav, Allen Andres, Frank Duong, Rajeev Mishra, Subhash Haldar et al.

Oncogene 2018 37 :4385 - 4397; May 02, 2018; 10.1038/s41388-018-0278-0

Abstract | Full Text

Myoferlin controls mitochondrial structure and activity in pancreatic ductal adenocarcinoma, and affects tumor aggressiveness

Gilles Rademaker, Vincent Hennequière, Laura Brohée, Marie-Julie Nokin, Pierre Lovinfosse et al.

Oncogene 2018 37 :4398 - 4412; May 03, 2018; 10.1038/s41388-018-0287-z

Abstract | Full Text

HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells

Matthew C. White, Rebecca D. Schroeder, Keyi Zhu, Katherine Xiong & David J. McConkey

Oncogene 2018 37 :4413 - 4427; May 03, 2018; 10.1038/s41388-018-0227-y

Abstract | Full Text

Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation

Dinesh K. Ahirwar, Mohd W. Nasser, Madhu M. Ouseph, Mohamad Elbaz, Maria C. Cuitiño et al.

Oncogene 2018 37 :4428 - 4442; May 03, 2018; 10.1038/s41388-018-0263-7

Abstract | Full Text

Recapitulation of pharmacogenomic data reveals that invalidation of SULF2 enhance sorafenib susceptibility in liver cancer

Sarah Yoon, Eun-Ju Lee, Ji-Hye Choi, Taek Chung, Do Young Kim et al.

Oncogene 2018 37 :4443 - 4454; May 03, 2018; 10.1038/s41388-018-0291-3

Abstract | Full Text

Loss-of-function of IFT88 determines metabolic phenotypes in thyroid cancer

Junguee Lee, Shinae Yi, Minho Won, Young Shin Song, Hyon-Seung Yi et al.

Oncogene 2018 37 :4455 - 4474; May 10, 2018; 10.1038/s41388-018-0211-6

Abstract | Full Text

Dual inhibition of BCL-XL and MCL-1 is required to induce tumour regression in lung squamous cell carcinomas sensitive to FGFR inhibition

Clare E. Weeden, Casey Ah-Cann, Aliaksei Z. Holik, Julie Pasquet, Jean-Marc Garnier et al.

Oncogene 2018 37 :4475 - 4488; May 10, 2018; 10.1038/s41388-018-0268-2

Abstract | Full Text

nature events
Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here.

Find the latest scientific conferences, courses, meetings and symposia on For event advertising opportunities across the Nature Publishing Group portfolio please contact
More Nature Events

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

Nature is part of Springer Nature. © 2018 Springer Nature Limited. All rights reserved.

Springer Nature

No comments: